Faculty

Back to Index
Nicholas Trakul, MD, PhD
Assistant Professor of Clinical Radiation Oncology
Radiation Oncology
NOR G349 1441 EASTLAKE AVE Health Sciences Campus Los Angeles
+1 323 865 3057

Publications

Chaudhuri AA, Binkley MS, Rigdon J, Carter JN, Aggarwal S, Dudley SA, Qian Y, Kumar KA, Hara WY, Gensheimer M, Nair VS, Maxim PG, Shultz DB, Bush K, Trakul N, Le QT, Diehn M, Loo BW, Guo HH. Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR). Radiother Oncol. 2016 Jun; 119(3):454-60. View in: PubMed

Soffietti R, Rudà R, Trakul N, Chang EL. Point/Counterpoint: Is stereotactic radiosurgery needed following resection of brain metastasis? Neuro Oncol. 2016 Jan; 18(1):12-5. View in: PubMed

Binkley MS, Trakul N, Jacobs LR, von Eyben R, Le QT, Maxim PG, Loo BW, Shultz DB, Diehn M. Colorectal Histology Is Associated With an Increased Risk of Local Failure in Lung Metastases Treated With Stereotactic Ablative Radiation Therapy. Int J Radiat Oncol Biol Phys. 2015 Aug 1; 92(5):1044-52. View in: PubMed

Chaudhuri AA, Tang C, Binkley MS, Jin M, Wynne JF, von Eyben R, Hara WY, Trakul N, Loo BW, Diehn M. Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors. Lung Cancer. 2015 Jul; 89(1):50-6. View in: PubMed

Binkley MS, Shrager JB, Leung AN, Popat R, Trakul N, Atwood TF, Chaudhuri A, Maxim PG, Diehn M, Loo BW. Lung volume reduction after stereotactic ablative radiation therapy of lung tumors: potential application to emphysema. Int J Radiat Oncol Biol Phys. 2014 Sep 1; 90(1):216-23. View in: PubMed

Shultz DB, Trakul N, Abelson JA, Murphy JD, Maxim PG, Le QT, Loo BW, Diehn M. Imaging features associated with disease progression after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer. Clin Lung Cancer. 2014 Jul; 15(4):294-301. e3. View in: PubMed

Shultz DB, Trakul N, Maxim PG, Diehn M, Loo BW. Vagal and recurrent laryngeal neuropathy following stereotactic ablative radiation therapy in the chest. Pract Radiat Oncol. 2014 Jul-Aug; 4(4):272-8. View in: PubMed

Trakul N, Koong AC, Chang DT. Stereotactic body radiotherapy in the treatment of pancreatic cancer. Semin Radiat Oncol. 2014 Apr; 24(2):140-7. View in: PubMed

Padda SK, Burt BM, Trakul N, Wakelee HA. Early-stage non-small cell lung cancer: surgery, stereotactic radiosurgery, and individualized adjuvant therapy. Semin Oncol. 2014 Feb; 41(1):40-56. View in: PubMed

Liu MB, Eclov NC, Trakul N, Murphy J, Diehn M, Le QT, Dieterich S, Maxim PG, Loo BW. Clinical impact of dose overestimation by effective path length calculation in stereotactic ablative radiation therapy of lung tumors. Pract Radiat Oncol. 2013 Oct-Dec; 3(4):294-300. View in: PubMed

Abelson JA, Murphy JD, Trakul N, Bazan JG, Maxim PG, Graves EE, Quon A, Le QT, Diehn M, Loo BW. Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy. Lung Cancer. 2012 Dec; 78(3):219-24. View in: PubMed

Trakul N, Chang CN, Harris J, Chapman C, Rao A, Shen J, Quinlan-Davidson S, Filion EJ, Wakelee HA, Colevas AD, Whyte RI, Dieterich S, Maxim PG, Hristov D, Tran P, Le QT, Loo BW, Diehn M. Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors. Int J Radiat Oncol Biol Phys. 2012 Sep 1; 84(1):231-7. View in: PubMed

Trakul N, Harris JP, Le QT, Hara WY, Maxim PG, Loo BW, Diehn M. Stereotactic ablative radiotherapy for reirradiation of locally recurrent lung tumors. J Thorac Oncol. 2012 Sep; 7(9):1462-5. View in: PubMed

Trakul N, Koong AC, Maxim PG, Chang DT. Modern radiation therapy techniques for pancreatic cancer. Gastroenterol Clin North Am. 2012 Mar; 41(1):223-35. View in: PubMed

Eves EM, Shapiro P, Naik K, Klein UR, Trakul N, Rosner MR. Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint. Mol Cell. 2006 Aug; 23(4):561-74. View in: PubMed

Trakul N, Menard RE, Schade GR, Qian Z, Rosner MR. Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation. J Biol Chem. 2005 Jul 1; 280(26):24931-40. View in: PubMed

Trakul N, Rosner MR. Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein. Cell Res. 2005 Jan; 15(1):19-23. View in: PubMed

Corbit KC, Trakul N, Eves EM, Diaz B, Marshall M, Rosner MR. Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J Biol Chem. 2003 Apr 11; 278(15):13061-8. View in: PubMed

Janulis M, Trakul N, Greene G, Schaefer EM, Lee JD, Rosner MR. A novel mitogen-activated protein kinase is responsive to Raf and mediates growth factor specificity. Mol Cell Biol. 2001 Mar; 21(6):2235-47. View in: PubMed

Powered bySC CTSI